Birth control patch

Birth control patch

The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Eric Wooltorton
Publisher: 
Canadian Medical Assocation Journal
Publication Date: 
2006
Publication Place: 
Ottawa, ON

Reviews the Evra patch and the potential for excess estrogen exposure raises concerns about the risks of adverse effects, which include nausea, breast tenderness and venous thromboembolism.

Available From: 
ISBN/ISSN: 
ISSN 0820-3946 (Print)
ISSN 1488-2329 (Online)
Notes: 
Includes bibliographical references.

Blood clots and the contraceptive patch

Tagged :
Print
Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
National Women's Health Network
Publisher: 
National Women's Health Network
Publication Date: 
2005
Publication Place: 
Washington, DC

Examines the risk of blood clots for women who use the contraceptive patch.

Evra and the environment

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Suzanne Elston
Publisher: 
Women and Health Protection
Publication Date: 
2004
Publication Place: 
Toronto, ON

Explains, by using the Evra patch as an example, how the drug approval process does not take drug disposal into account. Lists ways to prevent unused or expired medications from entering the ecosystem.

Available From: 

Hormonal methods of birth control

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
CBCA Sexual and Reproductive Wellness Centre
Publisher: 
CBCA Sexual and Reproductive Wellness Centre
Publication Place: 
Calgary, AB

Briefly describes and lists advantages and disadvantages of hormonal methods of birth control, including Depo-Provera, birth control pills, emergency contraceptive pills, the patch, and the ring.

Syndicate content